PH19203A - Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agent - Google Patents
Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agentInfo
- Publication number
- PH19203A PH19203A PH28429A PH28429A PH19203A PH 19203 A PH19203 A PH 19203A PH 28429 A PH28429 A PH 28429A PH 28429 A PH28429 A PH 28429A PH 19203 A PH19203 A PH 19203A
- Authority
- PH
- Philippines
- Prior art keywords
- monoacyloxy
- diacyloxy
- propoxymethyl
- purines
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
- C07C43/1785—Unsaturated ethers containing hydroxy or O-metal groups having more than one ether bound
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
- C07C43/1786—Unsaturated ethers containing hydroxy or O-metal groups containing halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34470382A | 1982-02-01 | 1982-02-01 | |
US07/451,262 US5250535A (en) | 1982-02-01 | 1982-12-22 | Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent |
Publications (1)
Publication Number | Publication Date |
---|---|
PH19203A true PH19203A (en) | 1986-01-31 |
Family
ID=26994067
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH28429A PH19203A (en) | 1982-02-01 | 1983-01-27 | Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agent |
PH30839A PH20099A (en) | 1982-02-01 | 1984-06-19 | Process for preparation of substituted 9-(1-or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines using carboxylic acid anhydrides or dicyclohexylcarbodiimide |
PH30840A PH20360A (en) | 1982-02-01 | 1984-06-19 | A process for preparing substituted 9-(1- or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines |
PH30841A PH22817A (en) | 1982-02-01 | 1984-06-19 | Process for preparing substituted 9-(1-or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines |
PH32259A PH22824A (en) | 1982-02-01 | 1985-05-13 | Process of preparing 9-(1- or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH30839A PH20099A (en) | 1982-02-01 | 1984-06-19 | Process for preparation of substituted 9-(1-or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines using carboxylic acid anhydrides or dicyclohexylcarbodiimide |
PH30840A PH20360A (en) | 1982-02-01 | 1984-06-19 | A process for preparing substituted 9-(1- or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines |
PH30841A PH22817A (en) | 1982-02-01 | 1984-06-19 | Process for preparing substituted 9-(1-or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines |
PH32259A PH22824A (en) | 1982-02-01 | 1985-05-13 | Process of preparing 9-(1- or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines |
Country Status (20)
Country | Link |
---|---|
US (1) | US5250535A (es) |
EP (1) | EP0085424A3 (es) |
KR (1) | KR890000191B1 (es) |
AU (2) | AU572777B2 (es) |
BR (1) | BR8300475A (es) |
DD (1) | DD206781A5 (es) |
DK (1) | DK29183A (es) |
ES (1) | ES519423A0 (es) |
FI (1) | FI79851C (es) |
GR (1) | GR81321B (es) |
HU (1) | HU193874B (es) |
IL (1) | IL67791A0 (es) |
IN (1) | IN157856B (es) |
NO (1) | NO161372C (es) |
NZ (1) | NZ203128A (es) |
PH (5) | PH19203A (es) |
PL (1) | PL140556B1 (es) |
PT (1) | PT76149B (es) |
RO (3) | RO86234B (es) |
ZW (1) | ZW2583A1 (es) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL141198B1 (en) * | 1981-08-11 | 1987-07-31 | Wellcome Found | Process for preparing derivatives of purine |
US4816447A (en) * | 1981-08-26 | 1989-03-28 | Merck & Co., Inc. | Anti-viral guanine compounds |
US4609662A (en) * | 1982-10-14 | 1986-09-02 | Burroughs Wellcome Co. | Method for using purine derivatives |
ATE33653T1 (de) * | 1982-10-14 | 1988-05-15 | Wellcome Found | Antivirale purinderivate. |
US4544634A (en) * | 1982-10-14 | 1985-10-01 | Burroughs Wellcome Co. | Method of producing acyclovir |
US4880820A (en) * | 1983-06-24 | 1989-11-14 | Merck & Co., Inc. | Guanine derivatives |
US4897479A (en) * | 1983-09-30 | 1990-01-30 | Merck & Co., Inc. | Arylsulfonyloxy purine intermediates |
EP0138683A3 (en) * | 1983-09-30 | 1988-01-20 | Merck & Co. Inc. | Purine derivatives, their application in anti-viral compositions |
IE842642L (en) * | 1983-10-31 | 1985-04-30 | Harvard College | Purine Derivatives |
IL73682A (en) * | 1983-12-20 | 1991-08-16 | Medivir Ab | Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation |
EP0152316B1 (en) * | 1984-01-26 | 1989-07-26 | Merck & Co. Inc. | Substituted butyl guanines and their utilization in antiviral compositions |
US4579849A (en) * | 1984-04-06 | 1986-04-01 | Merck & Co., Inc. | N-alkylguanine acyclonucleosides as antiviral agents |
WO1986000901A1 (en) * | 1984-07-20 | 1986-02-13 | Gauntt Charles O | Immunoregulatory and anti-viral compound |
FI91959C (fi) * | 1984-12-12 | 1994-09-12 | Syntex Inc | Menetelmä valmistaa alkoksimetyylieetteri- ja alkoksimetyyliesterijohdoksia |
EP0206497B1 (en) * | 1985-05-15 | 1994-07-20 | The Wellcome Foundation Limited | Therapeutic nucleosides and their preparation |
DE3627024A1 (de) * | 1985-09-24 | 1987-04-02 | Hoechst Ag | In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine |
US4966895A (en) * | 1989-02-02 | 1990-10-30 | Merck & Co. Inc. | Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents |
IE980216A1 (en) * | 1989-04-17 | 2000-02-23 | Scotia Holdings Plc | Anti-virals |
GB2260319B (en) | 1991-10-07 | 1995-12-06 | Norsk Hydro As | Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity |
US5670506A (en) * | 1993-04-05 | 1997-09-23 | Cell Therapeutics, Inc. | Halogen, isothiocyanate or azide substituted xanthines |
US5565565A (en) * | 1994-08-04 | 1996-10-15 | Syntex (U.S.A.) Inc. | Preparation of N-9 substituted guanine compounds |
US6060477A (en) * | 1995-06-07 | 2000-05-09 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives |
US6200980B1 (en) | 1995-06-07 | 2001-03-13 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl purinone derivatives |
US6262059B1 (en) | 1995-06-07 | 2001-07-17 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with quinazoline derivatives |
US6232312B1 (en) | 1995-06-07 | 2001-05-15 | Cell Pathways, Inc. | Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides |
US6046216A (en) * | 1995-06-07 | 2000-04-04 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives |
US5874440A (en) * | 1995-06-07 | 1999-02-23 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives |
US6046206A (en) * | 1995-06-07 | 2000-04-04 | Cell Pathways, Inc. | Method of treating a patient having a precancerous lesions with amide quinazoline derivatives |
US5840890A (en) * | 1996-01-26 | 1998-11-24 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
CA2238283C (en) * | 1997-05-30 | 2002-08-20 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
US5852035A (en) * | 1997-12-12 | 1998-12-22 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines |
US6410584B1 (en) * | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
US6046199A (en) * | 1998-01-14 | 2000-04-04 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives |
US5942520A (en) * | 1998-01-27 | 1999-08-24 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines |
US5990117A (en) * | 1998-04-15 | 1999-11-23 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives |
US6180629B1 (en) | 1998-08-14 | 2001-01-30 | Cell Pathways, Inc. | [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia |
US6124303A (en) * | 1998-09-11 | 2000-09-26 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones |
US6268372B1 (en) | 1998-09-11 | 2001-07-31 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones |
US6130053A (en) * | 1999-08-03 | 2000-10-10 | Cell Pathways, Inc. | Method for selecting compounds for inhibition of neoplastic lesions |
US6200771B1 (en) | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
US6187779B1 (en) | 1998-11-20 | 2001-02-13 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives |
US6369092B1 (en) | 1998-11-23 | 2002-04-09 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted benzimidazole derivatives |
US6077842A (en) * | 1998-11-24 | 2000-06-20 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives |
US6034099A (en) * | 1998-11-24 | 2000-03-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones |
US6486155B1 (en) | 1998-11-24 | 2002-11-26 | Cell Pathways Inc | Method of inhibiting neoplastic cells with isoquinoline derivatives |
US6025394A (en) | 1999-01-29 | 2000-02-15 | Cell Pathways, Inc. | Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols |
US6020379A (en) * | 1999-02-19 | 2000-02-01 | Cell Pathways, Inc. | Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
US6555547B1 (en) | 2000-02-28 | 2003-04-29 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative |
US6569638B1 (en) | 2000-03-03 | 2003-05-27 | Cell Pathways, Inc | Method for screening compounds for the treatment of neoplasia |
GB0708258D0 (en) * | 2007-04-27 | 2007-06-06 | Katholleke Universiteit Leuven | New anti-viral nulceoside analogs |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1523865A (en) * | 1974-09-02 | 1978-09-06 | Wellcome Found | Purine compunds and salts thereof |
US4199574A (en) * | 1974-09-02 | 1980-04-22 | Burroughs Wellcome Co. | Methods and compositions for treating viral infections and guanine acyclic nucleosides |
US4347360A (en) * | 1980-09-16 | 1982-08-31 | Ens Bio Logicals Inc. | Ring open nucleoside analogues |
US4355032B2 (en) * | 1981-05-21 | 1990-10-30 | 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent | |
PL141198B1 (en) * | 1981-08-11 | 1987-07-31 | Wellcome Found | Process for preparing derivatives of purine |
US4816447A (en) * | 1981-08-26 | 1989-03-28 | Merck & Co., Inc. | Anti-viral guanine compounds |
NZ201662A (en) * | 1981-08-26 | 1986-07-11 | Merck & Co Inc | 9-(1,3-(and 2,3)-dihydroxy-1-(and 2)-propoxy-methyl)guanine derivatives and methods for their preparation |
-
1982
- 1982-12-22 US US07/451,262 patent/US5250535A/en not_active Expired - Fee Related
-
1983
- 1983-01-25 DK DK29183A patent/DK29183A/da not_active Application Discontinuation
- 1983-01-26 FI FI830254A patent/FI79851C/fi not_active IP Right Cessation
- 1983-01-27 PH PH28429A patent/PH19203A/en unknown
- 1983-01-27 PT PT76149A patent/PT76149B/pt unknown
- 1983-01-31 RO RO109871A patent/RO86234B/ro unknown
- 1983-01-31 IL IL67791A patent/IL67791A0/xx unknown
- 1983-01-31 ZW ZW25/83A patent/ZW2583A1/xx unknown
- 1983-01-31 NO NO830316A patent/NO161372C/no unknown
- 1983-01-31 RO RO83114876A patent/RO89143A/ro unknown
- 1983-01-31 ES ES519423A patent/ES519423A0/es active Granted
- 1983-01-31 RO RO83114877A patent/RO89142A/ro unknown
- 1983-01-31 HU HU83314A patent/HU193874B/hu not_active IP Right Cessation
- 1983-01-31 GR GR70365A patent/GR81321B/el unknown
- 1983-01-31 NZ NZ203128A patent/NZ203128A/en unknown
- 1983-01-31 BR BR8300475A patent/BR8300475A/pt unknown
- 1983-01-31 KR KR1019830000360A patent/KR890000191B1/ko not_active IP Right Cessation
- 1983-01-31 PL PL1983240367A patent/PL140556B1/pl unknown
- 1983-01-31 EP EP83100886A patent/EP0085424A3/en not_active Withdrawn
- 1983-01-31 IN IN113/CAL/83A patent/IN157856B/en unknown
- 1983-01-31 DD DD83247593A patent/DD206781A5/de not_active IP Right Cessation
- 1983-02-01 AU AU10961/83A patent/AU572777B2/en not_active Ceased
-
1984
- 1984-06-19 PH PH30839A patent/PH20099A/en unknown
- 1984-06-19 PH PH30840A patent/PH20360A/en unknown
- 1984-06-19 PH PH30841A patent/PH22817A/en unknown
-
1985
- 1985-05-13 PH PH32259A patent/PH22824A/en unknown
-
1988
- 1988-03-03 AU AU12614/88A patent/AU1261488A/en not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH19203A (en) | Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agent | |
US4355032B2 (en) | 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent | |
PH23593A (en) | Difluoronucleosides as antiviral agents | |
CY1746A (en) | Antiviral guanine derivatives | |
GB2119650B (en) | Antiviral isothiosemicarbazones | |
ZA837642B (en) | Antiviral compounds | |
JPS5651423A (en) | Antiviral agent | |
AU564194B2 (en) | 9 - substituted guanines as antiviral agents | |
ZA837814B (en) | Antiviral agent | |
GB8330735D0 (en) | Pyrimidin-4-one derivatives | |
DE3468322D1 (en) | Antiviral agent | |
ZA83626B (en) | Substituted 9-(1 or 3-monoacyloxy or 1, 3-diacyloxy-2-propoxy-methyl purines as antiviral agent | |
GB2138418B (en) | Novel s-triazole(1,5-a)pyrimidine derivatives | |
ZA837691B (en) | (1,2,4)triazolo(4,3-a)quinoxaline-4-amine derivatives | |
GB2088366B (en) | Adenine derivatives | |
GB8306905D0 (en) | Substituted 1h-pyrazolo(1,5-a)pyrimidines | |
IE822049L (en) | Antiviral purines | |
GB8329344D0 (en) | Bronchodilatory azepino(1,2-a)pyrimidine derivatives | |
PH17379A (en) | 4-arylaliphatic-isoxazoles useful as antiviral agents | |
ZA886461B (en) | Antiviral agent | |
GB8728869D0 (en) | Antiviral agent | |
SG114493G (en) | Antiviral guanine derivatives | |
IE820064L (en) | 2-oxa-bicyclo(3,3,0)octanes | |
IE821160L (en) | Antiviral composition | |
ZM7883A1 (en) | Antiviral compounds |